Amrita Hospital, Faridabad collaborates with ImmunoACT to introduce CAR T-cell Therapy for Blood Cancer Patients
Jammu Tawi, Jan. 2 -- Amrita Hospital, Faridabad, in collaboration with ImmunoACT which is an IIT-Bombay incubated company, has introduced CAR T-cell (Chimeric antigen receptor) therapy for certain cancer patients, which is considered a significant breakthrough in B cell lymphoma and leukemia treatment, with promising results in relapsed and refractory patients. Four patients of B-cell Lymphoma have already undergone or are undergoing this therapy at Amrita Hospital so far and they are under follow-up.Dr. Prashant Mehta, Senior Consultant, Program Director (Lymphoid neoplasms & Cellular Therapy), Dept. of Medical Oncology / Hematoncology / BMT, Amrita Hospital, Faridabad said, "The treatment of cancer has improved immensely in the last fe...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.